FDA Inspection 1025002 — Xenex Laboratories Inc.

Xenex Laboratories Inc. — FEI 3007170694

The FDA completed an inspection of Xenex Laboratories Inc. on Sep 12, 2017 in Coquitlam. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 3 citations were issued during this inspection. Product area: Drugs.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Sep 12, 2017
Fiscal Year
2017
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Coquitlam (Canada)

Citations

IDCFRDescription
194221 CFR 211.180(e)Records reviewed annually
241921 CFR 211.198(a)Complaint Handling Procedure
356521 CFR 211.58Buildings not maintained in good state of repair

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.